Literature DB >> 11557553

Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury.

D Schulman1, D S Latchman, D M Yellon.   

Abstract

Ischemic preconditioning (IP) reduces infarct size in young animals; however, its impact on aging is underinvestigated. The effect of variations in IP stimuli was studied in young, middle-aged, and aged rat hearts. Isolated hearts underwent 35 min of regional ischemia and 120 min of reperfusion. Hearts with IP were subjected to either one ischemia-reperfusion cycle (5 min of ischemia and 5 min of reperfusion per cycle) or three successive cycles before 35 min of regional ischemia. Additional studies investigated the effects of pharmacological preconditioning in aged hearts using the adenosine A(1) receptor agonist 2-chloro-N(6)-cyclopentyladenosine, the protein kinase C analog 1,2-dioctanoyl-sn-glycerol, and the mitochondrial ATP-sensitive potassium (K(ATP))-channel opener diazoxide. Infarct sizes indicated that the aged rat heart could not be preconditioned via ischemic or pharmacological means. The middle-aged rat heart had a blunted IP response compared with the young adult (only an increased IP stimulus caused a significant reduction in infarct size). These results suggest that there are defects within the IP signaling cascade of the aged heart. Clinical relevance is important if we are to use any IP-like mimetics to the benefit of an aging population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557553     DOI: 10.1152/ajpheart.2001.281.4.H1630

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  52 in total

1.  Reduced mitochondrial Ca2+ loading and improved functional recovery after ischemia-reperfusion injury in old vs. young guinea pig hearts.

Authors:  Samhita S Rhodes; Amadou K S Camara; James S Heisner; Matthias L Riess; Mohammed Aldakkak; David F Stowe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-02       Impact factor: 4.733

Review 2.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

Review 3.  Adenosine receptors and reperfusion injury of the heart.

Authors:  John P Headrick; Robert D Lasley
Journal:  Handb Exp Pharmacol       Date:  2009

Review 4.  Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3.

Authors:  Karol Szczepanek; Qun Chen; Andrew C Larner; Edward J Lesnefsky
Journal:  Mitochondrion       Date:  2011-09-10       Impact factor: 4.160

5.  Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats.

Authors:  Nelson Escobales; Rebeca E Nuñez; Sehwan Jang; Rebecca Parodi-Rullan; Sylvette Ayala-Peña; Joshua R Sacher; Erin M Skoda; Peter Wipf; Walter Frontera; Sabzali Javadov
Journal:  J Mol Cell Cardiol       Date:  2014-10-23       Impact factor: 5.000

Review 6.  Ischaemic conditioning: pitfalls on the path to clinical translation.

Authors:  Karin Przyklenk
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 7.  Age-related differences in cardiac ischemia-reperfusion injury: effects of estrogen deficiency.

Authors:  Donna H Korzick; Timothy S Lancaster
Journal:  Pflugers Arch       Date:  2013-03-23       Impact factor: 3.657

8.  Exercise does not increase cyclooxygenase-2 myocardial levels in young or senescent hearts.

Authors:  John C Quindry; Joel French; Karyn L Hamilton; Youngil Lee; Josh Selsby; Scott Powers
Journal:  J Physiol Sci       Date:  2010-01-07       Impact factor: 2.781

Review 9.  Estrogen and the female heart.

Authors:  A A Knowlton; D H Korzick
Journal:  Mol Cell Endocrinol       Date:  2014-01-22       Impact factor: 4.102

10.  Cardioprotection and ageing.

Authors:  Yon Hee Shim
Journal:  Korean J Anesthesiol       Date:  2010-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.